More on HRMY
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $36.13 |
|
|||
| Open | $36.28 | ||||
| 52 Wk High | $1.35 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $37.19 | ||||
| Day Low | $36.13 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 448,974 | ||||
- Mizuhoon Harmony Biosciences (HRMY): 'we recommend being opportunistic on yesterday's share weakness'
- Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
- Ladenburg Thalmann Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy
- Form 8-K Harmony Biosciences Hold For: Oct 12
- H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
- Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
- Harmony Biosciences names new CEO effective January 2027
- Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
- Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
- Oppenheimer Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
Entities mentioned with HRMY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
